(Bloomberg) -- Takeda Pharmaceutical is developing a drug to treat people who have novel coronavirus or are at high risk of contracting it, Dow Jones reports, citing Rajeev Venkayya, president of its vaccine business.
- If tests are successful, Takeda will make the drug available in nine to 18 months.
To contact the reporter on this story: Max Zimmerman in Tokyo at mzimmerman90@bloomberg.net
To contact the editor responsible for this story: Niluksi Koswanage at nkoswanage@bloomberg.net
©2020 Bloomberg L.P.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
